Alzheimer’s disease (AD) diagnosis currently relies on the observation of cognitive impairments and memory loss. Developing tools enabling earlier diagnosis could help test new treatments that may be more effective when acting at early time points of the disease. While amyloid peptide plaque (A?) tracers used with PET imaging are now available to confirm the […]
Read More